KalVista Pharmaceuticals (KALV) Selling, General & Administrative (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -1.52 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 647.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 322.55 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | 44.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 44.68 Mn |
| Apr 30, 2025 | 39.14 Mn |
| Oct 31, 2024 | 29.20 Mn |
| Jul 31, 2024 | 17.60 Mn |
| Apr 30, 2024 | 23.21 Mn |
| Jan 31, 2024 | 10.63 Mn |
| Oct 31, 2023 | 10.66 Mn |
| Jul 31, 2023 | 9.79 Mn |
| Apr 30, 2023 | 7.78 Mn |
| Jan 31, 2023 | 6.88 Mn |
| Oct 31, 2022 | 7.81 Mn |
| Jul 31, 2022 | 8.13 Mn |
| Apr 30, 2022 | 7.60 Mn |
| Jan 31, 2022 | 6.95 Mn |
| Oct 31, 2021 | 6.06 Mn |
| Jul 31, 2021 | 5.85 Mn |
| Apr 30, 2021 | 6.17 Mn |
| Jan 31, 2021 | 3.56 Mn |
| Oct 31, 2020 | 3.63 Mn |
| Jul 31, 2020 | 3.28 Mn |
| Apr 30, 2020 | 3.30 Mn |
| Jan 31, 2020 | 3.07 Mn |
| Oct 31, 2019 | 3.42 Mn |
| Jul 31, 2019 | 3.25 Mn |
| Apr 30, 2019 | 3.05 Mn |
| Jan 31, 2019 | 2.90 Mn |
| Oct 31, 2018 | 2.61 Mn |
| Jul 31, 2018 | 2.37 Mn |
| Apr 30, 2018 | 1.96 Mn |
| Jan 31, 2018 | 2.13 Mn |
| Oct 31, 2017 | 2.70 Mn |
| Jul 31, 2017 | 2.07 Mn |
| Apr 30, 2017 | 2.20 Mn |
| Jan 31, 2017 | 5.03 Mn |
| Oct 31, 2016 | 1.29 Mn |
| Jul 31, 2016 | 2.70 Mn |
| Mar 31, 2016 | 1.54 Mn |
| Dec 31, 2015 | 1.32 Mn |
| Sep 30, 2015 | 1.37 Mn |
| Jun 30, 2015 | 1.17 Mn |
| Mar 31, 2015 | 1.01 Mn |
| Sep 30, 2014 | 1.49 Mn |
| Jun 30, 2014 | 691,000.00 |
| Mar 31, 2014 | 437,000.00 |